A Photoswitchable Inhibitor of the Human Serotonin Transporter
Open Access
- 10 April 2020
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 11 (9) , 1231-1237
Abstract
The human serotonin transporter (hSERT) terminates serotonergic signaling through reuptake of neurotransmitter into presynaptic neurons and is a target for many antidepressant drugs. We describe here the development of a photoswitchable hSERT inhibitor, termed azo-escitalopram, that can be reversibly switched between trans and cis configurations using light of different wavelengths. The dark-adapted trans isomer was found to be significantly less active than the cis isomer, formed upon irradiation.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS108151-01)
- Studienstiftung des Deutschen Volkes
- New York University
This publication has 45 references indexed in Scilit:
- Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental ChallengesJournal of Medicinal Chemistry, 2017
- Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identificationPharmacological Reports, 2013
- Future Directions for Serotonin and AntidepressantsACS Chemical Neuroscience, 2013
- Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter—a review of current understanding of its mechanism of actionPsychopharmacology, 2011
- The Two Enantiomers of Citalopram Bind to the Human Serotonin Transporter in Reversed OrientationsJournal of the American Chemical Society, 2010
- Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin TransporterJournal of Biological Chemistry, 2010
- The Expanded Biology of SerotoninAnnual Review of Medicine, 2009
- Serotonin ReceptorsChemical Reviews, 2008
- Targeting the murine serotonin transporter: insights into human neurobiologyNature Reviews Neuroscience, 2008
- Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)International Clinical Psychopharmacology, 1994